Chat
Multiple Myeloma, Daratumumab, Immunofixation
3003971
Copy Utility
Ordering Recommendation
Useful for monitoring treatment response and for assessing monoclonal antibody interference for patients with IgG kappa multiple myeloma being treated with daratumumab.
Mnemonic
MM DARA
Methodology
Qualitative Immunofixation Electrophoresis
Performed
Varies
Reported
4-9 days
New York DOH Approval Status
This test is New York DOH approved.
Specimen Required
Patient Preparation
Fasting specimen preferred.
Collect
Plain Red.
Specimen Preparation
Transfer 2 mL serum to an ARUP Standard Transport Tube. (Min: 1 mL)
Test is not performed at ARUP; separate specimens must be submitted when multiple tests are ordered.
Storage/Transport Temperature
Refrigerated. Also acceptable: Room temperature or frozen.
Unacceptable Conditions
Remarks
Stability
Ambient: 5 days; Refrigerated: 6 days; Frozen: 6 months
Reference Interval
By report
Interpretive Data
Compliance Category
Note
Hotline History
Hotline History
Date of Change
Test Name Change
Methodology
Performance/Reported Schedule
Specimen Requirements
Reference Interval
Interpretive Data
Note
CPT Code
Component Change
Other Interface Change
New Test
Inactive
N/A
CPT Codes
86334
Components
| Component Test Code* | Component Chart Name | LOINC |
|---|---|---|
| 3003972 | Multiple Myeloma, Daratumumab | 96420-5 |
* Component test codes cannot be used to order tests. The information provided here is not sufficient for interface builds; for a complete test mix, please click the sidebar link to access the Interface Map.
Aliases
- DARA
- Darzalex
Multiple Myeloma, Daratumumab, Immunofixation
Quest Diagnostics San Juan Capistrano Inc.
Feedback
